Selected  companies in the pharmacogenomics industry sector

A

B

C

D

E

F

G

H

I  J

L

M

N

O

P

Q

R

S

T

U

V

X

Z

Pharmacogenomics

A

Aclara Biosciences (Mountain View, CA, U.S.A.) (Biochips)

Affimetrix, Inc (Santa Clara, CA, U.S.A.)  - in agreement with Metabolex, Inc. (Hayward, CA)  (Biochips)

Anersham

Atugen (Max Delbruck Center for Molecular Medicine - Berlin, Germany; Facility also in Boulder, CO, U.S.A.)

Axys Pharmaceuticals' (S. San Francisco, CA, U.S.A.) Joint venture with PPD, Inc. (Wilmington, NC)

B

BioVeris Corporation ( http://www.bioveris.com ) - (Gaithersburg, Maryland, U.S.A.) - The company develops and markets biological detection systems, including electrochemiluminescence methods (clinical diagnostics, pharmaceutical research and development, life science research, biodefense testing and industrial food testing. BioVeris' tests are utilized in a wide variety of homeland Security and biodefense initiatives.

Blue Heron Biotechnology (Bothell, WA, U.S.A.) http://www.blueheronbio.com

C

Celera Genomisc (Rockville, MD, U.S.A.)  "G-Commerce"

Celltech Group (Berks, UL)

Chiroscience R&D (Seattle, WA, U.S.A.) , a division of Chiroscience Group plc (Cambridge, UK)

(Chiroscience and Celltech merger leads to Europe's largest biofirm)

Clinical MicroSensors (Pasadena, CA, U.S.A.) (Biochips)

Coley Pharmaceutical Group, Inc. (Wellesley, Massachusetts, U.S.A.) ( http://www.coleypharma.com ) - A new class of drugs that direct the immune system to treat chronic diseases 9cancers, infectious diseases, asthma, allergy) - +BIODEFENSE

CuraGen Corp. (New Haven, CT, U.S.A.) - CuraGen  has developed pharmacogenomics collaborations with Gllaxo Wellcome, Inc (Research Triangle Park, NC), Hoffmann-La Roche (Basel, Switzerland), COR Therapeutics (S. San Francisco, CA)  [Gene Scape Portal]

Cyclacel (UK)

D

deCODE genetics (Reykjavik, Iceland); agreement with Roche (Basel, Switzerland) (cloning novel and important disease genes)

Devgen (Belgium)

Develogen (Gottingen, Germany)

E

Epidauros Biotechnologie (Bernried, Germany) (information on human genetic variation, for potential applications to diseases and drugs response)

Eurona Medical AB (Uppsala, Sweden) (information on human genetic variation, for potential applications to diseases and drugs response)

Exon-Hit (Paris, France)

G

Galapagos  (Michelen, Belgium) - Joint venture between IntroGene (The Netherlands) and Tibotec (Belgium)

Gemini Research (Abingdon, Oxon, UK); recent acquisition od the pharmacogenomics company Eurona (Uppsala, Sweden); collaboration with Celera Genomics (Rockville, MA); agreement with Lineage Biomedical Inc. (St.John's, NF): the joint venture, Newfound Genomics, will establish a genetics-based research facility in Newfoundlan (Canada). (cloning novel and important disease genes)

Genaissance Pharmaceuticals (New Haven, CT, U.S.A.) (information on human genetic variation, for potential applications to diseases and drugs response)

Genome Pharmaceuticals Corp. (Munich, Germany) collaboration with Gene Alliance (Munich, Germany) [Gene alliance: Agowa (Berlin), Biomax Informatics (Munich), GATC (Konstanz), MediGenomix (The Martinsried - based subsidiary of Medi-Gene) and Qiagen

Genostic Pharma (Cambridge, UK) (information on human genetic variation, for potential applications to diseases and drugs response)

Genset (Paris) - Agreements with Abbott Laboratories (Abbott Park, IL) and with Pharmacia & Upjohn (Kalamazoo, MI) (information on human genetic variation, for potential applications to diseases and drugs response)

GenStar Therapeutics (San Diego, CA, U.S.A.)

GenVec,Inc. (Rockville, MD, U.S.A.)

Gene Logic (Gaithersburg, MD, U.S.A.)  "G-Commerce"

H

Hyseq (Sunnyvale, CA, U.S.A.) (Biochips) "G-Commerce"

Human Genome Sciences, Inc. (Rockville, MD, U.S.A.) "G-Commerce"

I

Illumina (San Diego, CA, U.S.A. (Biochips) (in agreement with PE Biosystems)

Incyte Pharmaceuticals,Inc (Palo Alto, CA, U.S.A.) with NV Organon (Oss, The Neverlands) (Biochips) "G-Commerce"

Inpharmatica (London) (Biopendium)

Institute for Systems Biology (Seattle, WA, U.S.A.)

IntroGene (Leiden, The Netherlands)

Galapagos Genomics (Michelen, Belgium) [(IntroGene in agreement with Tibotec (Mechelen, Belgium)]

J

Jmar Technologies, Inc. (San Diego, CA, U.S.A.)

M

Merus (EX Driebergen - The Netherlands) ( http://www.merus-biopharm.com ) - Development of technology for the high level expression of multiple human antibodies in clonal cell lines. Identification of mixture of antibodies for the identification and elimination of viral and bacterial pathogens. BIODEFENSE

Microscience Ltd (UK)

Millennium Predictive Medicine, Inc.'s [(a majority - owned subsidiary of Millennium Pharmaceuticals) Cambridge, MA, U.S.A.] alliance with Becton Dickinson and Company (Franklin Lakes, NJ, U.S.A.)

Millennium Predictive Medicine, Inc.'s (Cambridge, MA, U.S.A.) alliance with Brystol - Myers Squibb in the emerging field of cancer pharmacogenomics.

MWG Biotech AG (High Point, NC, U.S.A.; Ebersberg, Germany)

N

Nanogen (San Diego, CA, U.S.A.) (Biochips)

Nimbligen (Madison, Wis., U.S.A.) (Biochips)

Nanoplex Technologies, Inc. (Menlo Park, CA, U.S.A.) ( http://www.nanoplextech.com ) Nanotechnology for genomics.

O

Oxagen (Abingdon, Oxon, UK), collaboration with Lynx Therapeutics (Hayward, CA) for disease-associated single nucleotide polymorphisms (SNPs).

Oxford GlycoSciences (Abingdon, UK) , collaboration with Incyte (Palo Alto CA, U.S.A.)

P

PE Biosystems (Foster City, CA, U.S.A.); strategic collaboration with Illumina (San Diego, CA) for commercialization of high - throughput DNA array system. (PE Biosystems is a division of PE Corp., Norwalk, CT)  (Biochips)

Pharmagene (Hertfordshire, UK) "G-Commerce"

PharmaSeq (Monmouth Junction, NJ, U.S.A.) with an agreement with Sannoff Corp. (Princeton, NJ)

PPGx, Inc. (San Diego, CA, U.S.A.) the innovative source for pharmacogenomic products and services

Q

QT Genetics

R

Rosetta Inpharmatics (Kirkland, WA, U.S.A.)

S

SignalGene, Inc. (Montreal, Canada)

SNP Consortium Ltd. (it includes Wellcome Trust and ten pharmaceutical companies)  (SNPs = Single Nucleotide Polymorphisms) - Agreement with Orchid Biocomputer, Inc. (Princeton, NJ, U.S.A.)

T

The Whitehead Functional Genomics Consortium [Millennium Pharmaceuticals, Inc. (Cambridge, MA, U.S.A.), Bristol-Meyers Squibb Co. (new York City), Affimetrix Inc. (Santa Clara, CA, U.S.A.), the Wellcom Trust]

V

ValiGen [(Paris and Newtown, PA, U.S.A.) a merger from ValiGene (Paris) and Kimeragen (Newport, PA, U.S.A.), to create a EuroAmericam functional genomics company; agricultural division in San Diego, CA, U.S.A.]

Variagenics, Inc. (Cambridge, MA, U.S.A.) acquired exclusive rights to Nova Molecular Inc.'s (Montreal, Quebec) intellectual property (information on human genetic variation, for potential applications to diseases and drugs response)

Variagenics, Inc. (Cambridge, MA, U.S.A.) acquired exclusive rights to McGill University (Montreal, Quebec) intellectual property

Vascular Genetics, Inc. (Research Triangle Park, NC, U.S.A.)

Variagenics, Inc. (Cambridge, MA) and Quintiles Transnational Corp. (Research Triangle Park, NC, U.S.A.)

Vysis, Inc. (Downers Grove, IL, U.S.A.) in collabation with Eos Biotechnology, Inc.(South San Francisco, CA, U.S.A.)

Note: "G-Commerce" : is referred to companies that are selling genetic information (= genetic information providers)